What We Believe In?
The future will be a world where people heal with their own tissues and cells.
At REONEER, we are building that future today. We strive to transform regenerative medicine into a form that is not limited to a few centers but is widespread, natural, and sustainable—accessible to people and doctors in every corner of the world.
Healing does not come from the outside; it lies within each person.
Our mission is to bring forth that healing. And on this journey, standing beside humanity is our greatest responsibility.
Our Vision
To help people rediscover the healing power that comes from within their own nature and to make a healthier, happier life possible for everyone by combining this power with advanced technology.
Our Mission
At REONEER, we develop regenerative treatments based on the human body’s own potential, rather than relying on artificial or externally imposed solutions. We bring the latest scientific and clinical advancements in this field into practical application.
Our Inspiring Goal
To witness the moment when a doctor or an astronaut on a mission to Mars heals using a biological treatment derived from their own cells. In that moment, no shipment arrives from Earth. No pharmaceutical company is called. Only the human body—and the miracle it holds within—comes into action. Just like we’ve begun here on Earth. Wherever there is life, there will be healing. And we will be there.
Our Values
At REONEER, our core values define who we are and drive our mission
Respect for Life
We hold deep respect not only for humans but also for all living beings, nature, and the entirety of existence. Every solution we develop is built upon honoring life.
Sense of Responsibility
From the smallest laboratory process to major decisions that impact public health, we are aware of our responsibility at every step.
Perseverance and Determination
True transformations begin with patience and persistence. For us, success is not about achieving perfection the first time, but about relentlessly seeking what is right and progressing with unwavering determination along the path we believe in.
Freedom and Independence
Science thrives in free minds. From our clinical approaches to our commercial stance, we make independent decisions and move forward without compromising ethical principles. We are bound to no one but humanity and science.
Dear Business Partners and Colleagues,
At the intersection of science and technology, we believe in the inherent healing power of humans. At REONEER, our goal is not only to develop next-generation technologies but also to unleash the extraordinary potential of human cells.
The solutions we offer today in professional cosmetics and regenerative medicine are not just more effective protocols, but also the product of a vision centered on human benefit. For us, innovation is much more than a formula or device produced in the laboratory. Innovation allows people to rediscover themselves and step into a healthier, younger, and stronger future.
REONEER was built on the strong legacy of T-LAB. However, we don’t just preserve this legacy; we carry it forward, continuing to develop solutions that best meet the needs of doctors and specialists. Every product we develop reflects both our respect for science and our commitment to human life.
As we look to the future, our sole purpose is: Bringing a breath of fresh air to the world with an approach that combines science, aesthetics, and human health. I thank all the physicians, experts, and business partners who have joined us on this journey, and I invite you all to further advance humanity’s potential.
Sincerely,
T-LAB's Legacy
The Connection Between REONEER and T-LAB
As the founder and CEO of REONEER, Salih Özovalı invested in T-Biotechnology in 2015 by acquiring half of the company’s shares, shortly after it received its first CE certification in 2014. In 2018, the company registered the T-LAB brand in Turkey and many other countries and began investing in its development.
Today, Salih Özovalı still owns half of the T-LAB brand. REONEER, on the other hand, not only holds the sales rights of the T-LAB brand in many countries but also invests in new and innovative products and technologies beyond T-LAB.
Marketing Transformation
With over 10 years of experience in advertising agency and digital marketing, Salih Özovalı designed T-LAB's brand identity in 2018 and registered the brand both in Turkey and globally. With SEO and digital marketing investments, T-LAB's global visibility has been increased, and all domestic and international trade fair and congress events have been successfully managed.
Innovation in Production
Since 2015, numerous steps have been taken to elevate T-LAB's quality standards to a global level:
- Clean Room: The first clean room for packaging processes was established.
- Plastic Injection: Vacuum tubes were produced in-house, reducing external dependency.
- Sterilization Units: Standard quality in production has been ensured.
Furthermore, the company has been digitalized by integrating all processes from production to warehousing, from quality to accounting, using and developing with ERP, MRP etc. softwares.
In 2022, a new factory with a 3,000 m² indoor area was commissioned to meet MDR compliance and increase capacity. The company's R&D and production capacity was significantly strengthened with a 500 m² cleanroom, a new warehouse, a sterilization area, and 900 m² office space.
R&D Leadership
Salih Özovalı has been at the center of T-LAB's R&D activities.
- PRP Developments: CE-certified, economical PRP tubes, anticoagulant-free PRX tubes, and innovative PRP syringe projects were implemented.
- IMCAS Achievements: T-LAB achieved first high scores in IMCAS with the DEPA protocol.
- Microlyzer: With its mechanical SVF developments and unique designs, it has become a standard in the literature.
- Exosome Studies: A protocol that produces trillions of doses using a centrifuge alone has been developed, reaching a new level of exosome production.
- Technological Contributions: Contributed to the software and hardware development of the S-106 NXT centrifuge; many innovations, from syringe attachments to cannulas, were produced in-house.
REONEER's Vision
Salih Özovalı, the person who shaped T-LAB's marketing, production, and R&D capabilities, carries this knowledge and experience further into the REONEER brand. The goal is to provide innovative, reliable, and world-class solutions to leading physicians in regenerative medicine.
So why did T-LAB become REONEER?
Actually, it didn’t. One of T-LAB’s partners, Salih Özovalı, founded another regenerative medicine company as part of a new strategy to accelerate the company’s growth.
This new company is both the owner of the REONEER brand and also holds the global sales rights of T-LAB products in many countries.